Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Black

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
JAAPA : Official Journal of the American Academy of Physician Assistants|April 12, 2019
Patient knowledge of STI testing in an urban clinicKristy Goodman, Christopher M Black
Rheumatology International|October 5, 2017
Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitorsJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Plos One|February 27, 2016
Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World DataChristopher M Black, Eric Yu, Eilish McCann, et al.
Patient Preference and Adherence|February 2, 2017
Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment lineAxel Svedbom, Johan Dalén, Christopher M Black, et al.
Journal of Biomedical Informatics|December 15, 2021
Inferring the patient's age from implicit age clues in health forum postsChristopher M Black, Weilin Meng, Lixia Yao, et al.
Patient Preference and Adherence|March 24, 2017
Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across GermanyJohn Waller, Emma Sullivan, James Piercy, et al.
Plos One|April 15, 2017
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across GermanyEmma Sullivan, James Piercy, John Waller, et al.
International Journal of Alzheimer'S Disease|July 3, 2019
Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer's DiseaseDavneet Judge, Jenna Roberts, Rezaul Khandker, et al.
Advances in Therapy|August 20, 2023
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by IndicationJohan Dalén, Axel Svedbom, Emma Hernlund, et al.
Advances in Therapy|November 8, 2021
Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective StudyJohan Dalén, Amy Puenpatom, Karin Luttropp, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
JAAPA : Official Journal of the American Academy of Physician Assistants|April 12, 2019
Patient knowledge of STI testing in an urban clinicKristy Goodman, Christopher M Black
Rheumatology International|October 5, 2017
Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitorsJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Plos One|February 27, 2016
Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World DataChristopher M Black, Eric Yu, Eilish McCann, et al.
Patient Preference and Adherence|February 2, 2017
Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment lineAxel Svedbom, Johan Dalén, Christopher M Black, et al.
Journal of Biomedical Informatics|December 15, 2021
Inferring the patient's age from implicit age clues in health forum postsChristopher M Black, Weilin Meng, Lixia Yao, et al.
Patient Preference and Adherence|March 24, 2017
Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across GermanyJohn Waller, Emma Sullivan, James Piercy, et al.
Plos One|April 15, 2017
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across GermanyEmma Sullivan, James Piercy, John Waller, et al.
International Journal of Alzheimer'S Disease|July 3, 2019
Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer's DiseaseDavneet Judge, Jenna Roberts, Rezaul Khandker, et al.
Advances in Therapy|August 20, 2023
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by IndicationJohan Dalén, Axel Svedbom, Emma Hernlund, et al.
Advances in Therapy|November 8, 2021
Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective StudyJohan Dalén, Amy Puenpatom, Karin Luttropp, et al.
Pageof 7